ELF stock forecast, quote, news & analysis

Key Takeaways

• e.l.f. Beauty reported Q3 fiscal 2026 net sales up 38% to $489.5 million, beating estimates, with adjusted EBITDA rising 79% to $123 million.
• Raised fiscal 2026 guidance to 22-23% net sales growth ($1.60-1.612 billion), driven by strong Rhode brand performance contributing $260-265 million.
• Stock experienced volatility in recent weeks, declining amid post-earnings reaction and negative Super Bowl ad feedback, despite analyst consensus pointing to significant upside.
• e.l.f. Cosmetics gained 130 basis points in market share, highlighting ongoing category leadership.
• Analysts maintain a Moderate Buy rating with an average price target of $119, implying over 50% potential upside from recent levels.

Current Market Snapshot

In recent trading sessions, e.l.f. Beauty (ELF) stock has shown heightened volatility amid a broader downward trend, reflecting investor digestion of quarterly results and high-profile marketing efforts. The shares have pulled back from mid-January peaks near $94, trading in the mid-$70s amid elevated volumes during key sessions. This price action underscores sensitivity to earnings reactions and external sentiment factors, even as fundamentals demonstrate robust growth through channel expansion and brand acquisitions. Broader beauty sector dynamics, including consumer demand for affordable cosmetics, continue to support the company's positioning, though short-term swings highlight the need to monitor execution against raised expectations.

Recent Developments Driving ELF Price Action

e.l.f. Beauty's stock price has been influenced by a series of key events over the past 30 days, blending strong operational performance with mixed market reactions. The standout catalyst was the February 4 release of third-quarter fiscal 2026 results for the period ended December 31, 2025. Net sales surged 38% year-over-year to $489.5 million, surpassing consensus estimates of around $460 million, fueled by growth across U.S. and international retailer and e-commerce channels. Adjusted diluted EPS reached $1.24, well above the $0.72 forecast, while adjusted EBITDA climbed 79% to $123 million, or 25% of sales. Gross margin dipped slightly by 30 basis points to 71% due to elevated tariff costs, but was partly offset by pricing and product mix improvements.

The results prompted an upward revision to fiscal 2026 guidance, now projecting 22-23% net sales growth to $1.60-1.612 billion, up from the prior 18-20% range of $1.55-1.57 billion. Adjusted EBITDA outlook rose to $323-326 million, with adjusted EPS at $3.05-3.10. Management attributed much of the momentum to the recently acquired Rhode brand, which contributed $128 million in Q3—about 36 percentage points of growth—and is now expected to deliver $260-265 million for the year, implying roughly 70% annualized expansion. Rhode's record-breaking launch at Sephora UK bolstered international traction, while the core e.l.f. Cosmetics brand captured 130 basis points of market share, extending its streak of category-leading gains over 28 quarters.

Despite the beat, shares dipped modestly post-earnings, closing up slightly on February 4 but falling sharply the next day amid perceptions that the guidance raise—while positive—fell short of some aggressive expectations. Trading volumes spiked to over 5.5 million shares on February 5, signaling profit-taking. CEO Tarang Amin emphasized the company's value proposition, innovation pipeline, and disruptive marketing as enduring drivers, with nine-month net sales up 21% to $1.187 billion.

Marketing initiatives added visibility but mixed sentiment. On February 3, e.l.f. unveiled its telenovela-inspired Super Bowl campaign featuring Melissa McCarthy, Nicholas Gonzalez, and Itatí Cantoral, aimed at Hispanic demographics and extending across platforms for a 300 million reach. However, post-Super Bowl critiques from outlets like The New York Times' The Athletic labeled the "Melisa" ad as one of the "worst," citing lack of humor, contributing to an 8.5-9% single-day drop on February 9 to around $74-75.

Earlier, a January 22 partnership with H&M for a fragrance collaboration signaled product diversification. Analyst responses were largely supportive: JPMorgan raised its target to $105 from $103, Citigroup to $115, though TD Cowen trimmed to $100 from $110 on February 9. Consensus remains Moderate Buy, with average targets around $112-119, reflecting optimism on Rhode integration and share gains despite near-term volatility.

2026 Outlook and Key Factors to Monitor

As e.l.f. Beauty advances through fiscal 2026, investors should track the seamless integration of Rhode and its sustained high-teens growth trajectory, alongside core e.l.f. brand market share expansion amid competitive pressures in mass cosmetics. International scaling, particularly Rhode's Sephora rollouts in Europe and potential tariff headwinds on imports, will influence margins, which management aims to stabilize near 70% through pricing discipline and supply chain efficiencies. Innovation across skincare, fragrances—like the H&M collaboration—and color cosmetics, paired with elevated marketing spend (24-26% of sales), remains pivotal for capturing Gen Z and multicultural consumers drawn to affordable, viral products.

Broader industry shifts, including beauty consumption growth projected at 6% globally, e-commerce acceleration, and macroeconomic resilience in discretionary spending, offer tailwinds. Risks include softer organic trends in regions like the UK and Germany, rising promotional reliance, and acquisition-related debt servicing with $817 million outstanding against $197 million cash. Competitive positioning versus premium players and execution on Q4 guidance—31-33% second-half sales growth—will shape sentiment, with analysts forecasting EPS of $3.10 for the year.